Who is sponsoring NCT05610358?

NCT05610358 is sponsored by Asan Medical Center.

What drugs are being tested in NCT05610358?

Interventions in NCT05610358: smartphone application.

What condition does NCT05610358 study?

NCT05610358 studies Pulmonary Rehabilitation, Cardiac Rehabilitation.

Is NCT05610358 still recruiting?

NCT05610358 is currently status unknown. Last updated 5 July 2023.

Last reviewed 2023-07-05 · How we verify

NCT05610358

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Smartphone Application Based Rehabilitations in Patients With Chronic Respiratory or Cardiovascular Disease

Status unknown NA Last updated 5 July 2023

What this trial tests

NA trial testing smartphone application in Pulmonary Rehabilitation in 162 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
31 December 2023

31 December 2024

Quick facts

Lead sponsor	Asan Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	162
Start date	1 April 2023
Primary completion	31 December 2023
Estimated completion	31 December 2024
Sites	1 location across South Korea

Drugs / interventions tested

smartphone application

Conditions studied

Pulmonary Rehabilitation — all drugs for Pulmonary Rehabilitation →
Cardiac Rehabilitation — all drugs for Cardiac Rehabilitation →

Sponsor

Asan Medical Center

Who can join

Adults 20 to 80, any sex, with Pulmonary Rehabilitation or Cardiac Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In Republic of Korea, it is not easy to practice standard pulmonary rehabilitation (PR) or cardiac rehabilitation (CR). In this study, the investigators will provide newly developed smartphone application to patients with chronic respiratory or cardiovascular diseases. The investigators want to confirm whether participants, who perform smartphone application based 12-week PR or CR program, present improved exercise capacity, dyspnea symptom, muscle strength, or quality of life.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Smartphone application-based rehabilitation in patients with chronic respiratory and cardiovascular diseases: a randomised controlled trial study protocol.
Chung C, Kim AR, Jang IY, Jo MW, et al · · 2023 · cited 2× · PMID 37730392 · DOI 10.1136/bmjopen-2023-072698
Clinical Efficacy of Smartphone App-Based Pulmonary Rehabilitation in Chronic Respiratory Diseases: Randomized Controlled and Feasibility Trials.
Chung C, Kim AR, Kang DY, Kim S, et al · · 2025 · PMID 41313804 · DOI 10.2196/76801

Verify or expand the search:

Other trials of smartphone application

Trials testing the same drug.

NCT05383950 — Rehabilitation of Chronic Diseases and Smart Health Management System Service · NA · unknown

Other recruiting trials for Pulmonary Rehabilitation

Currently open trials in the same condition.

NCT07430943 — Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation · NA · recruiting
NCT07185178 — Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS · NA · recruiting
NCT07061444 — Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients · NA · recruiting
NCT06998550 — Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye · recruiting
NCT07195838 — Mindful-Breath for People With COPD · NA · recruiting

Other Asan Medical Center trials

Trials by the same sponsor.

NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05610358 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
Last refreshed: 5 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05610358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing